. . . . . . . . . . . . "[the MAPK stimulation of ERalpha activity involves the phosphorylation not only of S118 but also of S104 and S106; MAPK-mediated hyperphosphorylation of ERalpha at these sites may contribute to resistance to tamoxifen in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:32:55+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .